- Home
- CVRX vs EIC Comparison
CVRX vs EIC Comparison
Compare CVRX & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- EIC
- Stock Information
- Founded
- CVRX 2000
- EIC N/A
- Country
- CVRX United States
- EIC United States
- Employees
- CVRX N/A
- EIC N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- EIC Finance/Investors Services
- Sector
- CVRX Health Care
- EIC Finance
- Exchange
- CVRX Nasdaq
- EIC Nasdaq
- Market Cap
- CVRX 419.8M
- EIC 352.9M
- IPO Year
- CVRX 2021
- EIC 2019
- Fundamental
- Price
- CVRX $6.25
- EIC $13.91
- Analyst Decision
- CVRX Strong Buy
- EIC Strong Buy
- Analyst Count
- CVRX 7
- EIC 1
- Target Price
- CVRX $16.83
- EIC $17.50
- AVG Volume (30 Days)
- CVRX 516.2K
- EIC 284.8K
- Earning Date
- CVRX 05-08-2025
- EIC 05-20-2025
- Dividend Yield
- CVRX N/A
- EIC 17.20%
- EPS Growth
- CVRX N/A
- EIC N/A
- EPS
- CVRX N/A
- EIC 1.97
- Revenue
- CVRX $51,292,000.00
- EIC $46,223,036.00
- Revenue This Year
- CVRX $22.17
- EIC $39.61
- Revenue Next Year
- CVRX $24.02
- EIC $27.28
- P/E Ratio
- CVRX N/A
- EIC $7.08
- Revenue Growth
- CVRX 30.53
- EIC 72.79
- 52 Week Low
- CVRX $5.87
- EIC $12.73
- 52 Week High
- CVRX $18.55
- EIC $16.71
- Technical
- Relative Strength Index (RSI)
- CVRX 25.78
- EIC 39.38
- Support Level
- CVRX $5.91
- EIC $13.78
- Resistance Level
- CVRX $6.71
- EIC $14.83
- Average True Range (ATR)
- CVRX 0.84
- EIC 0.47
- MACD
- CVRX -0.43
- EIC -0.04
- Stochastic Oscillator
- CVRX 5.28
- EIC 47.77
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.